XML 110 R80.htm IDEA: XBRL DOCUMENT v3.24.0.1
Collaborations - BeiGene (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 02, 2020
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Total revenues   $ 28,190 $ 26,323 $ 25,979
Due from related party   7,268 5,563  
Due from related party   2,602 2,388  
BeiGene        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Research and development arrangement, contract to provide cash and development services, maximum amount $ 1,250      
BeiGene | Related Party        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Due from related party   16 6  
Due from related party   44 47  
BeiGene        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Equity method investment, aggregate cost $ 2,800      
Research and development | BeiGene        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Cost recoveries   109 199 220
Selling, general and administrative | BeiGene        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Profit and loss share of expenses   40 53 64
BeiGene | BeiGene        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Total revenues   $ 125 $ 64 $ 72